Nepean Valley Eye Surgeons Interactive Optometry Night 2026
Date: 4/03/2026 (AEDT)
Venue: The Log Cabin - The Bridgeview Room 20 Memorial Ave Penrith NSW 2750, NSW, 2750
Provider: Nepean Valley Eye Surgeons
Contact: Ursula M Kunicki, [E] ursula@nepeaneye.com.au, [P] 0247215899
Activity Outline
Nepean Valley Eye Surgeons is an established practice located in the heart of Penrith servicing Greater Western Sydney and Blue Mountains community.
Please join us on Wednesday 4th of March for an interactive and informative Optometry Event. Thanks to our sponsor Inservio and Ophthalmapro for their support. Ophthalmapro will have an interactive dry eye display on the night with hands on experience for optometrists. Apellis will also have an interactive station set up for optometrists with the ability to try Syfovre injections and to learn more about this product in treating geographic atrophy.
The event will be held at The Log Cabin - The Bridgeview Room with beautiful outlook over the Nepean River. It will give optometrists the opportunity to mingle with the ophthalmologists and staff from Nepean Valley Eye Surgeons and to allow for networking opportunities with fellow colleagues.
The presentations on the night will include: Our director Dr Gayatri Banerjee and our associates Dr Dov Hersh and Dr Paul Adler. Michelle Glassington from Apellis will also be doing a talk on updates on Syfovre. Talks will allow for interactive discussion time to engage with your fellow peers and the surgeons. Test your knowledge multiple choice questions will also be included.
Event Details:
Date: Wednesday 4th of March 2026
Time: 6pm- 10pm
Location: The Log Cabin- the Bridgeview Room
A wonderful space with views of Nepean River full buffet dinner and drinks.
We look forward to meeting you at this wonderful event.
Learning Objectives
- Understand the evolution of artificial intelligence—from early machine learning approaches to modern deep neural networks.
- Become familiar with current AI systems and applications available in eye care.
- Define oculomics and understand its relevance to ophthalmic practice.
- Recognise the potential risks and challenges associated with integrating AI into healthcare.
- Gain insight into emerging developments and future directions for AI in ophthalmology.
- Develop an understanding of the pathophysiology of geographic atrophy.
- Understand how complement inhibitors act to slow the progression of geographic atrophy.
- Review the evidence supporting the use of complement inhibitors in the treatment of geographic atrophy.
- Understand the side-effect profile of complement inhibitor therapy
- What to tell patients regarding the availability of complement inhibitors in Australia in 2026.
- Understand the significance of false-positives and false-negatives in ancillary testing for glaucoma including field tests and OCT
- Clinically being able to differentiate conditions including systemic disease that present / mimic glaucoma but are not
- Being able to differentiate field loss that presents like glaucoma but is not
- Variations in intraocular pressure that are not apparent and the clinical significance of this
- Be familiar with the changes in first line management in glaucoma treatment- including the role of lasers
- Know when to refer patients for cataract surgery
- Understand the role of an intraocular lens
- Gain a better understanding of modern lens technology - monofocal / toric / trifocal/ multifocal/EDOF
- How to determine lens selection in patients what clinical factors need to be considered
- Importance of management of dry eye in optimising surgical outcomes in cataract surgery
- Understanding the possible side effects of the different intraocular lenses available
- Challenges of post-Lasik patients in lens selection how calculations have improved over time
- Understanding the application of secondary IOL lenses when they can be used
- Gain improved understanding with regards to diagnosing post-operative complications and possible treatments
Max CPD hours awarded: 2
Session Information
| Name |
|---|
| AI, Oculomics and Beyond? |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| No |
| Duration of CPD Session/Module |
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| An Update on Treatment for Geographic Atrophy |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| When Glaucoma is not Glaucoma! |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.25 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |
| Name |
|---|
| IOL selection in Optimising outcomes in cataract surgery |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 0.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 0.5 |